Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership112,442 shares
Latest Disclosed Value $ 14,813,110
Citigroup Inc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 112,442 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $14,813,110 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 103,273 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 8.88% during the quarter.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 18,000 of underlying shares valued at $2,371,320 USD and put options representing 18,000 of underlying shares valued at $2,371,320 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 112,442 9,169 8.88 14,813 1.13 0.0032
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 103,273 -133,809 -56.44 14,647 -55.99 0.0065
2025-11-10 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 237,082 -84,982 -26.39 33,282 -17.78 0.0148
2025-08-11 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 322,064 -144,125 -30.92 40,480 -21.49 0.0199
2025-05-12 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 466,189 301,009 182.23 51,561 128.68 0.0264
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 165,180 -35,339 -17.62 22,547 -2.41 0.0134
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200,519 84,230 72.43 23,104 44.31 0.0134
2024-08-12 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 116,289 -38,789 -25.01 16,010 -25.15 0.0103
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 155,078 -16,855 -9.80 21,388 -5.58 0.0140
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 171,933 -17,915 -9.44 22,654 6.07 0.0160
2023-12-06 2023-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 189,848 -19,273 -9.22 21,358 8.30 0.0160
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 189,848 -19,273 21,358 0.0159
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 209,121 -9,666 -4.42 19,720 -10.95 0.0129
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 218,787 80,811 58.57 22,146 34.38 0.0155
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 137,976 2,390 1.76 16,480 14.44 0.0131
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 135,586 40,677 42.86 14,400 55.64 0.0103
2022-08-10 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 94,909 33,104 53.56 9,252 59.68 0.0069
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 61,805 -44,956 -42.11 5,794 -36.28 0.0035
2022-02-10 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 106,761 43,336 68.33 9,093 49.46 0.0049
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 63,425 -39,776 -38.54 6,084 -39.42 0.0036
2021-08-10 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 103,201 -6,576 -5.99 10,043 -5.93 0.0060
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 109,777 2,753 2.57 10,676 4.09 0.0069
2021-02-11 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 107,024 20,450 23.62 10,257 23.19 0.0061
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 86,574 4,947 6.06 8,326 -16.40 0.0054
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 81,627 17,385 27.06 9,959 79.12 0.0078
2020-05-12 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,242 22,141 52.59 5,560 22.87 0.0050
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 42,101 -12,049 -22.25 4,525 -7.27 0.0033
2019-11-08 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 54,150 -29,154 -35.00 4,880 -30.62 0.0039
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 83,304 39,178 88.79 7,034 80.92 0.0057
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,126 -24,723 -35.91 3,888 -20.93 0.0037
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 68,849 40,511 142.96 4,917 41.13 0.0050
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,338 -8,985 -24.07 3,484 -4.99 0.0031
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,323 17,325 86.63 3,667 121.17 0.0034
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,998 486 2.49 1,658 9.51 0.0014
2018-02-12 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,512 -20,673 -51.44 1,514 -38.53 0.0012
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,185 7,468 22.83 2,463 63.65 0.0020
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 32,717 -21,378 -39.52 1,505 -35.74 0.0014
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 54,095 -113,758 -67.77 2,342 -63.95 0.0021
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 167,853 145,527 651.83 6,496 474.36 0.0059
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,326 5,971 36.51 1,131 52.02 0.0011
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,355 -68,548 -80.74 744 -77.85 0.0008
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 84,903 58,428 220.69 3,359 124.23 0.0038
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,475 8,449 46.87 1,498 108.93 0.0015
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,026 2,336 14.89 717 -4.40 0.0007
2015-08-13 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,690 -2,120 -11.90 750 6.08 0.0007
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,810 -11,110 -38.42 707 9.44 0.0007
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,920 25,678 792.04 646 1,192.00 0.0006
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,242 -83 -2.50 50 0.00 0.0000
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,325 -15,221 -82.07 50 -83.22 0.0000
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,546 -12,427 -40.12 298 3.11 0.0003
2014-02-14 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 30,973 14,077 83.32 289 51.31 0.0003
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,896 10,206 152.56 191 114.61 0.0002
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,690 6,690 89 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 18,000 -40.00 2,371 -44.26 n/a n/a n/a
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 4,255 n/a n/a n/a
2025-08-11 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Call 57,000 111.11 6,304 71.07 n/a n/a n/a
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 27,000 -41.05 3,686 -30.17 n/a n/a n/a
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 45,800 5,277 n/a n/a n/a
2024-08-12 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 0.00 4,138 4.68 n/a n/a n/a
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 3,953 n/a n/a n/a
2023-12-06 2023-09-30 13F/A NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 0 n/a n/a n/a
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Call 60,000 100.00 5,658 86.36 n/a n/a n/a
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 3,037 n/a n/a n/a
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Call 19,000 1,361.54 2,018 1,488.98 n/a n/a n/a
2022-08-10 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Call 1,300 127 n/a n/a n/a
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 11,600 93.33 1,112 92.72 n/a n/a n/a
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 6,000 -41.18 577 -53.62 n/a n/a n/a
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 10,200 -36.25 1,244 -10.18 n/a n/a n/a
2020-05-12 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 16,000 -31.62 1,385 -44.93 n/a n/a n/a
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 23,400 -20.95 2,515 -5.70 n/a n/a n/a
2019-11-08 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 29,600 46.53 2,667 56.42 n/a n/a n/a
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 20,200 -16.53 1,705 -20.03 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 24,200 44.05 2,132 77.67 n/a n/a n/a
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Call 16,800 740.00 1,200 387.80 n/a n/a n/a
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Call 2,000 -60.78 246 -50.90 n/a n/a n/a
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Call 5,100 168.42 501 217.09 n/a n/a n/a
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Call 1,900 0.00 158 7.48 n/a n/a n/a
2018-02-12 2017-12-31 13F NEUROCRINE BIOSCIENCES COM Call 1,900 -44.12 147 -29.33 n/a n/a n/a
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM Call 3,400 -92.72 208 -90.32 n/a n/a n/a
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM Call 46,700 4,145.45 2,148 4,375.00 n/a n/a n/a
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Call 1,100 22.22 48 37.14 n/a n/a n/a
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Call 900 -99.30 35 -99.46 n/a n/a n/a
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Call 129,100 5.39 6,538 17.44 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Call 122,500 61,150.00 5,567 69,487.50 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COM Call 200 -95.00 8 -96.46 n/a n/a n/a
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Call 4,000 3,900.00 226 5,550.00 n/a n/a n/a
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Call 100 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 18,000 -40.00 2,371 -44.26 n/a n/a n/a
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 4,255 n/a n/a n/a
2025-08-11 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-12 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 57,000 111.11 6,304 71.07 n/a n/a n/a
2025-02-12 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Put 27,000 -54.62 3,686 -46.24 n/a n/a n/a
2024-11-12 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Put 59,500 6,856 n/a n/a n/a
2024-08-12 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 0.00 4,138 4.68 n/a n/a n/a
2024-02-09 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 3,953 n/a n/a n/a
2023-12-06 2023-09-30 13F/A NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 0 0 n/a n/a n/a
2023-08-10 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Put 60,000 100.00 5,658 86.36 n/a n/a n/a
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 3,037 n/a n/a n/a
2023-02-09 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-10 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 19,000 2,018 n/a n/a n/a
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 14,300 -81.74 1,371 -81.79 n/a n/a n/a
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 78,300 11.38 7,529 -12.22 n/a n/a n/a
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Put 70,300 105.56 8,577 189.76 n/a n/a n/a
2020-05-12 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 34,200 8.92 2,960 -12.30 n/a n/a n/a
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 31,400 -7.37 3,375 10.47 n/a n/a n/a
2019-11-08 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 33,900 -13.74 3,055 -7.93 n/a n/a n/a
2019-08-12 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 39,300 19.45 3,318 14.49 n/a n/a n/a
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 32,900 -53.99 2,898 -43.24 n/a n/a n/a
2019-02-12 2018-12-31 13F NEUROCRINE BIOSCIENCES COM Put 71,500 544.14 5,106 274.07 n/a n/a n/a
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM Put 11,100 91.38 1,365 139.47 n/a n/a n/a
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM Put 5,800 -46.30 570 -36.31 n/a n/a n/a
2018-05-11 2018-03-31 13F NEUROCRINE BIOSCIENCES COM Put 10,800 315.38 895 343.07 n/a n/a n/a
2018-02-12 2017-12-31 13F NEUROCRINE BIOSCIENCES COM Put 2,600 -93.43 202 -91.68 n/a n/a n/a
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM Put 39,600 -7.26 2,427 23.57 n/a n/a n/a
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM Put 42,700 4,170.00 1,964 4,467.44 n/a n/a n/a
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM Put 1,000 400.00 43 437.50 n/a n/a n/a
2017-02-10 2016-12-31 13F NEUROCRINE BIOSCIENCES COM Put 200 -60.00 8 -68.00 n/a n/a n/a
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM Put 500 0.00 25 8.70 n/a n/a n/a
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM Put 500 150.00 23 187.50 n/a n/a n/a
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COM Put 200 -91.30 8 -93.85 n/a n/a n/a
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COM Put 2,300 76.92 130 150.00 n/a n/a n/a
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM Put 1,300 52 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.